Global Markets. Belgian Perspective. An independent Belgian financial markets publication in English.

FINANCEMARKETS.INFO

Tag: blockbuster drugs

Analysis

Bimzelx generated €1.52 billion in the first half of 2026. Could UCB’s flagship immunology medicine eventually be worth more than €20 billion?

August 6, 202612 min read